211 related articles for article (PubMed ID: 37284308)
61. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
[TBL] [Abstract][Full Text] [Related]
62. Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing.
Kimpton JE; Carey IM; Threapleton CJD; Robinson A; Harris T; Cook DG; DeWilde S; Baker EH
Br J Clin Pharmacol; 2019 Dec; 85(12):2734-2746. PubMed ID: 31454087
[TBL] [Abstract][Full Text] [Related]
63. Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
Mroz P; Michel S; Allen JD; Meyer T; McGonagle EJ; Carpentier R; Vecchia A; Schlichte A; Bishop JR; Dunnenberger HM; Yohe S; Thyagarajan B; Jacobson PA; Johnson SG
Front Genet; 2021; 12():712602. PubMed ID: 34745204
[TBL] [Abstract][Full Text] [Related]
64. Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.
Hellwig LD; Turner C; Olsen C; Libbus J; Markos B; Koehlmoos T; Haigney M; De Castro M; Saunders D
Mil Med; 2024 Jan; 189(1-2):e198-e204. PubMed ID: 37436924
[TBL] [Abstract][Full Text] [Related]
65. Pharmacogenomic profile of a central European urban random population-Czech population.
Proietti R; Maranho Neto GA; Kunzova S; Lo Re O; Ahola-Olli A; Heliste J; Gonzalez-Rivas JP; Vinciguerra M
PLoS One; 2023; 18(4):e0284386. PubMed ID: 37079615
[TBL] [Abstract][Full Text] [Related]
66. Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
Westergaard N; Baltzer Houlind M; Christrup LL; Juul-Larsen HG; Strandhave C; Olesen AE
Basic Clin Pharmacol Toxicol; 2024 Apr; 134(4):531-542. PubMed ID: 38308569
[TBL] [Abstract][Full Text] [Related]
67. Harnessing Knowledge on Very Important Pharmacogenes CYP2C9 and CYP2C19 Variation for Precision Medicine in Resource-Limited Global Conflict Zones.
Barlas İÖ; Sezgin O; Dandara C; Türköz G; Yengel E; Cindi Z; Ankaralı H; Şardaş S
OMICS; 2016 Oct; 20(10):604-609. PubMed ID: 27726640
[TBL] [Abstract][Full Text] [Related]
68. Population Diversity in Pharmacogenetics: A Latin American Perspective.
Suarez-Kurtz G; Parra EJ
Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
[TBL] [Abstract][Full Text] [Related]
69. Projected Utility of Pharmacogenomic Testing Among Individuals Hospitalized With COVID-19: A Retrospective Multicenter Study in the United States.
Stevenson JM; Alexander GC; Palamuttam N; Mehta HB
Clin Transl Sci; 2021 Jan; 14(1):153-162. PubMed ID: 33085221
[TBL] [Abstract][Full Text] [Related]
70. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study.
Just KS; Dormann H; Schurig M; Böhme M; Fracowiak J; Steffens M; Scholl C; Seufferlein T; Gräff I; Schwab M; Stingl JC
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32527038
[TBL] [Abstract][Full Text] [Related]
71. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.
Wang L; Scherer SE; Bielinski SJ; Muzny DM; Jones LA; Black JL; Moyer AM; Giri J; Sharp RR; Matey ET; Wright JA; Oyen LJ; Nicholson WT; Wiepert M; Sullard T; Curry TB; Rohrer Vitek CR; McAllister TM; St Sauver JL; Caraballo PJ; Lazaridis KN; Venner E; Qin X; Hu J; Kovar CL; Korchina V; Walker K; Doddapaneni H; Wu TJ; Raj R; Denson S; Liu W; Chandanavelli G; Zhang L; Wang Q; Kalra D; Karow MB; Harris KJ; Sicotte H; Peterson SE; Barthel AE; Moore BE; Skierka JM; Kluge ML; Kotzer KE; Kloke K; Vander Pol JM; Marker H; Sutton JA; Kekic A; Ebenhoh A; Bierle DM; Schuh MJ; Grilli C; Erickson S; Umbreit A; Ward L; Crosby S; Nelson EA; Levey S; Elliott M; Peters SG; Pereira N; Frye M; Shamoun F; Goetz MP; Kullo IJ; Wermers R; Anderson JA; Formea CM; El Melik RM; Zeuli JD; Herges JR; Krieger CA; Hoel RW; Taraba JL; St Thomas SR; Absah I; Bernard ME; Fink SR; Gossard A; Grubbs PL; Jacobson TM; Takahashi P; Zehe SC; Buckles S; Bumgardner M; Gallagher C; Fee-Schroeder K; Nicholas NR; Powers ML; Ragab AK; Richardson DM; Stai A; Wilson J; Pacyna JE; Olson JE; Sutton EJ; Beck AT; Horrow C; Kalari KR; Larson NB; Liu H; Wang L; Lopes GS; Borah BJ; Freimuth RR; Zhu Y; Jacobson DJ; Hathcock MA; Armasu SM; McGree ME; Jiang R; Koep TH; Ross JL; Hilden MG; Bosse K; Ramey B; Searcy I; Boerwinkle E; Gibbs RA; Weinshilboum RM
Genet Med; 2022 May; 24(5):1062-1072. PubMed ID: 35331649
[TBL] [Abstract][Full Text] [Related]
72. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
[TBL] [Abstract][Full Text] [Related]
73. Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.
Mostafa S; Polasek TM; Sheffield LJ; Huppert D; Kirkpatrick CMJ
Front Psychiatry; 2021; 12():724170. PubMed ID: 34489765
[No Abstract] [Full Text] [Related]
74. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
Socco S; Wake DT; Lee JC; Dunnenberger HM
Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
[TBL] [Abstract][Full Text] [Related]
75. Pharmacogenomic findings from clinical whole exome sequencing of diagnostic odyssey patients.
Cousin MA; Matey ET; Blackburn PR; Boczek NJ; McAllister TM; Kruisselbrink TM; Babovic-Vuksanovic D; Lazaridis KN; Klee EW
Mol Genet Genomic Med; 2017 May; 5(3):269-279. PubMed ID: 28546997
[TBL] [Abstract][Full Text] [Related]
76. A Pilot Study for Return of Individual Pharmacogenomic Results to Population-Based Cohort Study Participants.
Ohneda K; Hiratsuka M; Kawame H; Nagami F; Suzuki Y; Suzuki K; Uruno A; Sakurai-Yageta M; Hamanaka Y; Taira M; Ogishima S; Kuriyama S; Hozawa A; Tomita H; Minegishi N; Sugawara J; Danjoh I; Nakamura T; Kobayashi T; Yamaguchi-Kabata Y; Tadaka S; Obara T; Hishimuma E; Mano N; Matsuura M; Sato Y; Nakasone M; Honkura Y; Suzuki J; Katori Y; Kakuta Y; Masamune A; Aoki Y; Nakayama M; Kure S; Kinoshita K; Fuse N; Yamamoto M
JMA J; 2022 Apr; 5(2):177-189. PubMed ID: 35611229
[TBL] [Abstract][Full Text] [Related]
77. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
[TBL] [Abstract][Full Text] [Related]
78. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
Sahana S; Sivadas A; Mangla M; Jain A; Bhoyar RC; Pandhare K; Mishra A; Sharma D; Imran M; Senthivel V; Divakar MK; Rophina M; Jolly B; Batra A; Sharma S; Siwach S; Jadhao AG; Palande NV; Jha GN; Ashrafi N; Mishra PK; Vidhya AK; Jain S; Dash D; Kumar NS; Vanlallawma A; Sarma RJ; Chhakchhuak L; Kalyanaraman S; Mahadevan R; Kandasamy S; Devi P; Rajagopal RE; Ramya JE; Devi PN; Bajaj A; Gupta V; Mathew S; Goswami S; Prakash S; Joshi K; Kumla M; Sreedevi S; Gajjar D; Soraisham R; Yadav R; Devi YS; Gupta A; Mukerji M; Ramalingam S; Binukumar BK; Sivasubbu S; Scaria V
Pharmacogenomics; 2021 Jul; 22(10):603-618. PubMed ID: 34142560
[No Abstract] [Full Text] [Related]
79. CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations-Implication for Drug Safety, Dosing, and Individualized Therapy.
Langmia IM; Just KS; Yamoune S; Brockmöller J; Masimirembwa C; Stingl JC
Front Genet; 2021; 12():692234. PubMed ID: 34322158
[TBL] [Abstract][Full Text] [Related]
80. Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population.
Sivadas A; Sahana S; Jolly B; Bhoyar RC; Jain A; Sharma D; Imran M; Senthivel V; Divakar MK; Mishra A; Mukhopadhyay A; Gibson G; Narayan KV; Sivasubbu S; Scaria V; Kurpad AV
BMJ Open Diabetes Res Care; 2024 Mar; 12(2):. PubMed ID: 38471670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
